NCT04079660View on ClinicalTrials.gov

Glycemic Control Based on Serum Fructosamine Concentration vs. hemoglobinA1c (HbA1c) in Diabetic Patients

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

February 1, 2021

Study Completion Date

February 1, 2021

Conditions
Diabetes
Interventions
DIAGNOSTIC_TEST

Capillary blood glucose blood draw

Capillary blood glucose (CBG), HbA1c, fructosamine, albumin, BUN, and creatinine values will be obtained from a blood draw as a standard of care

Trial Locations (1)

43210

The Ohio State University Wexner Medical Center, Columbus

All Listed Sponsors
lead

Ohio State University

OTHER

NCT04079660 - Glycemic Control Based on Serum Fructosamine Concentration vs. hemoglobinA1c (HbA1c) in Diabetic Patients | Biotech Hunter | Biotech Hunter